2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (2203):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-133681A
    2,3-Dibromosuccinic acid
    2,3-Dibromosuccinic acid is the isomer of (±)-2,3-Dibromosuccinic acid (HY-133681), and can be used as an experimental control. (±)-2,3-Dibromosuccinic acid is the key intermediate in the synthesis of dicarboxylic acid derivatives.
    2,3-Dibromosuccinic acid
  • HY-Z9464
    Fluprostenol lactone diol
    		Control
    Fluprostenol lactone diol is an intermediate used in the preparation of Fluprostenol (HY-136494).
    Fluprostenol lactone diol
  • HY-W320685
    (S)-N-Boc-L-homoserine ethyl ester
    		Control
    (S)-N-Boc-L-homoserine ethyl ester is a synthetic intermediate in the synthesis of unsaturated caprolactams and monomer units for oxy-peptide nucleic acids from the starting material L-homoserine.
    (S)-N-Boc-L-homoserine ethyl ester
  • HY-W094155
    Methyl (1S)-3-oxocyclopentaneacetate
    		Control
    Methyl (1S)-3-oxocyclopentaneacetate is a synthetic intermediate useful for pharmaceutical synthesis.
    Methyl (1S)-3-oxocyclopentaneacetate
  • HY-W598456
    Brigimadlin intermediate-1
    Brigimadlin intermediate-1 is an intermediate of the E3 ubiquitin protein ligase MDM-2 inhibitor Brigimadlin (HY-152859) and can be used to synthesize Antibody-Drug Conjugates (ADCs) .
    Brigimadlin intermediate-1
  • HY-Z4729
    Linagliptin impurity 13
    Linagliptin impurity 13 is an impurity of Linagliptin (HY-10284).
    Linagliptin impurity 13
  • HY-78048R
    Ticagrelor impurity 6 (Standard)
    Ticagrelor impurity 6 (Standard) is the analytical standard of Ticagrelor impurity 6 (HY-78048). This product is intended for research and analytical applications.
    Ticagrelor impurity 6 (Standard)
  • HY-W881463
    N4-Ac-C-(S)-GNA phosphoramidite
    N4-Ac-C-(S)-GNA phosphoramidite is an important intermediate for the synthesis of nucleic acids and their analogs.
    N4-Ac-C-(S)-GNA phosphoramidite
  • HY-W653776
    (6a,11β)-11,20-Dihydroxy-6-methyl-3-oxopregna-1,4,17(20)-trien-21-al
    (6a,11β)-11,20-Dihydroxy-6-methyl-3-oxopregna-1,4,17(20)-trien-21-al is a Methylprednisolon (HY-B0260) impurity.
    (6a,11β)-11,20-Dihydroxy-6-methyl-3-oxopregna-1,4,17(20)-trien-21-al
  • HY-W587536
    N-Demethyl lincomycin hydrochloride
    N-Demethyl lincomycin (4'-Propyl-N-demethyllincomycin) hydrochloride is a Lincomycin (HY-117660) impurity.
    N-Demethyl lincomycin hydrochloride
  • HY-Z4291
    Sitagliptin impurity 2
    		98.61%
    Sitagliptin impurity 2 is an impurity of Sitagliptin (HY-13749).
    Sitagliptin impurity 2
  • HY-131121
    4-Isobutylbenzoic acid
    		99.20%
    4-Isobutylbenzoic acid is an intermediate in the synthesis of compounds.
    4-Isobutylbenzoic acid
  • HY-136301
    Acid secretion-IN-1
    Acid secretion-IN-1 is a polycyclic compound extracted from patent WO2018024188A1, Compound Example 17.4. Acid secretion-IN-1 is synthesized and used in the IDO inhibitor synthetic experiment.
    Acid secretion-IN-1
  • HY-Z6404
    Palbociclib impurity 40
    Palbociclib impurity 40 is an impurity of Palbociclib (HY-50767).
    Palbociclib impurity 40
  • HY-Z4705
    Etoricoxib impurity 7
    Etoricoxib impurity 7 is an impurity of Etoricoxib (HY-15321).
    Etoricoxib impurity 7
  • HY-Z1963
    Rosuvastatin impurity 54
    Rosuvastatin impurity 54 is an impurity of Rosuvastatin (HY-17504A).
    Rosuvastatin impurity 54
  • HY-I0543
    Canagliflozin impurity 4
    Canagliflozin impurity 4 is an impurity of Canagliflozin (HY-10451).
    Canagliflozin impurity 4
  • HY-Z4213
    Dabigatran impurity 9
    Dabigatran impurity 9 is an impurity of Dabigatran (HY-10163).
    Dabigatran impurity 9
  • HY-400690
    TAM558 intermediate-4
    TAM558 intermediate-4 is an intermediate in the synthesis of TAM558 (HY-148127).TAM558 is the payload molecule used in the synthesis of OMTX705.OMTX705 is a humanized anti-fibroblast activation protein (FAP) antibody that binds to the cytolysin TAM470 (HY-148128) and has anti-tumor activity.
    TAM558 intermediate-4
  • HY-I0684
    Canagliflozin impurity 79
    Canagliflozin impurity 79 is an impurity of Canagliflozin (HY-10451).
    Canagliflozin impurity 79